215 related articles for article (PubMed ID: 18415984)
1. Cytochrome P450 BM-3 evolved by random and saturation mutagenesis as an effective indole-hydroxylating catalyst.
Li HM; Mei LH; Urlacher VB; Schmid RD
Appl Biochem Biotechnol; 2008 Jan; 144(1):27-36. PubMed ID: 18415984
[TBL] [Abstract][Full Text] [Related]
2. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution.
Pengpai Z; Sheng H; Lehe M; Yinlin L; Zhihua J; Guixiang H
Appl Biochem Biotechnol; 2013 Sep; 171(1):93-103. PubMed ID: 23817788
[TBL] [Abstract][Full Text] [Related]
3. Directed evolution of the fatty-acid hydroxylase P450 BM-3 into an indole-hydroxylating catalyst.
Li QS; Schwaneberg U; Fischer P; Schmid RD
Chemistry; 2000 May; 6(9):1531-6. PubMed ID: 10839169
[TBL] [Abstract][Full Text] [Related]
4. Rational evolution of a medium chain-specific cytochrome P-450 BM-3 variant.
Li QS; Schwaneberg U; Fischer M; Schmitt J; Pleiss J; Lutz-Wahl S; Schmid RD
Biochim Biophys Acta; 2001 Feb; 1545(1-2):114-21. PubMed ID: 11342037
[TBL] [Abstract][Full Text] [Related]
5. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
6. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
7. Protein engineering of the cytochrome P450 monooxygenase from Bacillus megaterium.
Urlacher VB; Schmid RD
Methods Enzymol; 2004; 388():208-24. PubMed ID: 15289074
[No Abstract] [Full Text] [Related]
8. A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.
Schwaneberg U; Schmidt-Dannert C; Schmitt J; Schmid RD
Anal Biochem; 1999 May; 269(2):359-66. PubMed ID: 10222011
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of CYP102G4 from Streptomyces cattleya: A self-sufficient P450 naturally producing indigo.
Kim J; Lee PG; Jung EO; Kim BG
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):60-67. PubMed ID: 28821467
[TBL] [Abstract][Full Text] [Related]
10. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
Peters MW; Meinhold P; Glieder A; Arnold FH
J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
[TBL] [Abstract][Full Text] [Related]
11. Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.
Wong TS; Arnold FH; Schwaneberg U
Biotechnol Bioeng; 2004 Feb; 85(3):351-8. PubMed ID: 14748091
[TBL] [Abstract][Full Text] [Related]
12. A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes.
Appel D; Lutz-Wahl S; Fischer P; Schwaneberg U; Schmid RD
J Biotechnol; 2001 Jun; 88(2):167-71. PubMed ID: 11403851
[TBL] [Abstract][Full Text] [Related]
13. Role of the linker region connecting the reductase and heme domains in cytochrome P450BM-3.
Govindaraj S; Poulos TL
Biochemistry; 1995 Sep; 34(35):11221-6. PubMed ID: 7669780
[TBL] [Abstract][Full Text] [Related]
14. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
15. Protein engineering of toluene ortho-monooxygenase of Burkholderia cepacia G4 for regiospecific hydroxylation of indole to form various indigoid compounds.
Rui L; Reardon KF; Wood TK
Appl Microbiol Biotechnol; 2005 Jan; 66(4):422-9. PubMed ID: 15290130
[TBL] [Abstract][Full Text] [Related]
16. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
[TBL] [Abstract][Full Text] [Related]
17. Regioselectivity-driven evolution of CYP102D1 for improved synthesis of 3'-ortho-dihydroxyisoflavone.
Choi KY; Yang YH; Kim BG
Enzyme Microb Technol; 2015 Apr; 71():20-7. PubMed ID: 25765306
[TBL] [Abstract][Full Text] [Related]
18. Sensitive assay for laboratory evolution of hydroxylases toward aromatic and heterocyclic compounds.
Wong TS; Wu N; Roccatano D; Zacharias M; Schwaneberg U
J Biomol Screen; 2005 Apr; 10(3):246-52. PubMed ID: 15809320
[TBL] [Abstract][Full Text] [Related]
19. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
[TBL] [Abstract][Full Text] [Related]
20. Random mutagenesis of human cytochrome p450 2A6 and screening with indole oxidation products.
Nakamura K; Martin MV; Guengerich FP
Arch Biochem Biophys; 2001 Nov; 395(1):25-31. PubMed ID: 11673862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
